Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Pzena Investment Management, Inc. (PZN)
|
Add to portfolio |
|
|
|
| Price: |
$9.61
| | Metrics |
| OS: |
73.7
|
M
| |
11
|
% ROE
|
| Market cap: |
$708
|
M
| |
49
|
% ROIC
|
|
Net cash:
|
$49.4
|
M
| |
$0.67
|
per share
|
|
EV:
|
$659
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$104
|
M
| |
6.4
|
x EV/EBITDA
|
|
EBIT
|
$104
|
M
| |
6.3
|
x EV/EBIT
|
| EPS |
$0.18
| |
53.5
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 199.3 | 138.6 | 150.7 | 153.6 | 141.3 | 108.3 | 116.6 | 112.5 |
| Revenue growth | 43.8% | -8.0% | -1.8% | 8.7% | 30.4% | -7.1% | 3.6% | 17.5% |
| Cost of goods sold | 77.1 | 68.5 | 88.1 | 61.4 | 58.9 | 48.3 | 46.5 | 41.3 |
| Gross profit | 122.3 | 70.1 | 62.6 | 92.2 | 82.4 | 60.0 | 70.1 | 71.2 |
| Gross margin | 61.3% | 50.6% | 41.6% | 60.0% | 58.3% | 55.4% | 60.1% | 63.3% |
| Selling, general and administrative | 93.5 | 83.3 | | | | | | |
| General and administrative | | | 17.0 | 13.4 | 13.3 | 12.8 | 14.7 | 10.3 |
| EBIT | 104.9 | 54.9 | 47.6 | 76.4 | 70.6 | 48.5 | 55.3 | 61.0 |
| EBIT margin | 52.6% | 39.6% | 31.6% | 49.8% | 49.9% | 44.7% | 47.4% | 54.2% |
| Pre-tax income | 114.3 | 55.8 | 51.3 | 76.1 | 94.7 | -0.8 | 52.1 | 56.9 |
| Income taxes | 7.8 | 4.3 | 5.8 | 7.8 | 34.5 | -54.5 | 5.1 | 1.9 |
| Tax rate | 6.8% | 7.7% | 11.3% | 10.2% | 36.5% | 6611.0% | 9.8% | 3.3% |
| Net income | 18.7 | 8.9 | 8.5 | 13.8 | 6.9 | 16.2 | 7.7 | 8.1 |
| Net margin | 9.4% | 6.4% | 5.6% | 9.0% | 4.9% | 14.9% | 6.6% | 7.2% |
| |
| Diluted EPS | $0.22 | $0.11 | $0.11 | $0.19 | $0.10 | $0.23 | $0.11 | $0.12 |
| Shares outstanding (diluted) | 84.0 | 79.1 | 74.2 | 71.9 | 70.9 | 68.8 | 68.1 | 67.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|